Skip to main content
Clinical Trials/NCT05749198
NCT05749198
Completed
Not Applicable

Non-invasive Assessment of Portal Hypertension Using Quantitative Magnetic Resonance Imaging

Yonsei University1 site in 1 country47 target enrollmentJanuary 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Portal Hypertension
Sponsor
Yonsei University
Enrollment
47
Locations
1
Primary Endpoint
Change of liver stiffness and spleen stiffness by MRE
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This prospective study was conducted in a tertiary university hospital. The investigators researched the correlation between MRE-assessed stiffness of the liver and spleen and the Hepatic venous pressure gradient (HVPG) values. Furthermore, the investigator evaluated whether MRE-assessed stiffness reflected changes in portal hypertension (PH) after administering non-selective beta-blockers (NSBBs).

Registry
clinicaltrials.gov
Start Date
January 2, 2018
End Date
January 28, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Moon Young Kim

Professor

Yonsei University

Eligibility Criteria

Inclusion Criteria

  • diagnosed liver cirrhosis
  • requiring prophylactic treatment of esophageal varices

Exclusion Criteria

  • the coexistence of hepatocellular carcinoma
  • refractory ascites who regularly underwent large-volume paracentesis
  • the use of selective beta-blocker or carvedilol therapy for at least 4 weeks
  • undergoing liver transplantation
  • contraindication with magnetic resonance imaging

Outcomes

Primary Outcomes

Change of liver stiffness and spleen stiffness by MRE

Time Frame: Change from baseline stiffness of MRE at 6 months

The change of portal pressure (HVPG) prior to and after treatment with NSBB

Time Frame: Change from baseline and at 6 months

Study Sites (1)

Loading locations...

Similar Trials